Cargando...
Targeting and Therapeutic Peptide-Based Strategies for Polycystic Kidney Disease
Polycystic kidney disease (PKD) is characterized by progressive cyst growth and is a leading cause of renal failure worldwide. Currently, there are limited therapeutic options available to PKD patients, and only one drug, tolvaptan, has been FDA-approved to slow cyst progression. Similar to other sm...
Gardado en:
| Publicado en: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736157/ https://ncbi.nlm.nih.gov/pubmed/32866560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2020.08.011 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|